Alzheimer’s disease poses a health problem of pandemic proportions. It is estimated that by the year 2030 there will be greater than 60 million people worldwide with AD, and $375 … Continue Reading Newly identified role for ApoE explains its effects in Alzheimer’s.
The standard model of natural selection predicts that once the age of reproduction ends, individuals die. That’s because selection early in life strongly favors variants that benefit reproductive success, even … Continue Reading Study identifies gene variants which protect older adults from neurodegeneration.
Alzheimer’s is a devastating disease whose incidence is on the rise globally. ApoE-4, a particular allele of the apolipoprotein apoE, is a known risk factor. Since apoE plays a critical … Continue Reading Women with Alzheimer’s-risk gene lose weight more sharply after age 70.
Air pollution is a serious public health issue and exposures to concentrations of air pollutants at or above the current standards has been linked to neuroinflammation and neurodegeneration. In the … Continue Reading Study shows that air pollution has detrimental impact on Alzheimer’s risk gene.
Today, more than 5.1 million Americans live with Alzheimer’s disease, a devastating type of dementia that plagues memory and thinking. That number is expected to triple in the coming decades. … Continue Reading Work begins on turning an ApoE4 Alzheimer’s brain into an ApoE2 Alzheimer’s brain.
Through studying brain scans and cerebrospinal fluid of healthy adults researchers at Washington University have shown that changes in key biomarkers of Alzheimer’s disease during midlife can help identify those who … Continue Reading First ever large-scale human study validates multiple biomarkers for Alzheimer’s disease.
Scientists at Rigshopitalet, Herlev Hospital and the University of Copenhagen identify a new biomarker that can predict the risk of developing dementia by way of a simple blood test. In … Continue Reading Large-scale study validates simple blood test for dementia.
Research suggests anti-inflammatory protein, interleukin 10, may trigger plaque in Alzheimer’s disease.
Inflammation has long been studied in Alzheimer’s, but in a counterintuitive finding, University of Florida researchers have uncovered the mechanism by which anti-inflammatory processes may trigger the disease. This anti-inflammatory … Continue Reading Research suggests anti-inflammatory protein, interleukin 10, may trigger plaque in Alzheimer’s disease.
It’s known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What’s less known is that cholesterol levels … Continue Reading Scientists identify marker that predicts changes in cholesterol levels as people grow older.